Using double immunofluorescence labelling for CD34 and αSMA, we observed coexpression of both markers in stromal cells of scleroderma (Figure 4E), which supports the notion that resident CD34+SCs/TCs may be a source of myofibroblasts in this lesion. Here, ACTA1 is linked to scleroderma.